Biotech Orphalan becomes the first European company to enter in China’s Wilson Disease market March 7, 2025
Biotech Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma March 6, 2025
Biotech GenAssist Ltd Announces FDA Clearance of Investigational New Drug Application for GEN6050X, a Globally First-in-Class Base Editing Drug for Duchenne Muscular Dystrophy March 6, 2025
Biotech XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene’s Commercial Presence in APAC March 5, 2025
Biotech Bioheng Therapeutics Announces FDA Clearance of IND Application for CD7 UCAR T Cell Therapy in T-ALL/LBL March 5, 2025
Biotech UPM Annual Report 2024, Corporate Governance Statement and Remuneration Report published March 5, 2025
Biotech CStone Announces First Patient Dosed in Global Multicenter Phase I Clinical Trial of CS2009, a PD-1/VEGF/CTLA-4 Trispecific Antibody March 4, 2025
Biotech Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA® March 4, 2025
Biotech BioRes Ruizhi BLC Implant System Showcased in China, Addressing Rising Demand for High-quality Implants March 3, 2025
Search
Biotech
March 7, 2025
March 6, 2025
March 6, 2025
March 5, 2025
March 5, 2025
March 5, 2025
March 5, 2025
March 4, 2025
March 4, 2025
March 3, 2025
